Integrated Cancer Repository for Cancer Research

Introduction

• Org Study ID: 0253-13-EP
• NTC ID: NCT02012699
• Lead Sponsor Name: University of Nebraska
• Status: RECRUITING

Conditions

• Renal Cell Carcinoma

Brief Summary

The iCaRe2 is a multi-institutional resource created and maintained by the Fred & Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.

Eligibility Criteria

Inclusion Criteria.

* Adult individuals (male and female) who have a personal diagnosis/history of cancer
* Adult individuals who have a risk for developing cancer or suspicious clinical findings
* Adult individuals with no history of cancer for normal control registry.
* Able to provide consent.
* 19 years of age or older.
* Adult individuals who are able to speak English or Spanish.

Exclusion Criteria.

* Individuals under age 19.
* Individuals unable to provide informed consent by virtue of cognitive impairment.
* Anyone who does not meet the above inclusion criteria for this project.
* Non-English or Non-Spanish speaking individuals.